|
1
|
Laachir A, Guesmi S, Ketatni EM, Saadi M, El Ammari L, Esserti S, Faize M, Bentiss F. Novel 1-D copper(II) coordination polymer based on 2,5-bis(pyridine-2-yl)-1,3,4-thiadiazole as bridging ligand: Synthesis, crystal structure, Hirshfeld surface analysis, spectroscopic characterizations and biological assessment. J Mol Struct 2020. [DOI: 10.1016/j.molstruc.2020.128533] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
|
|
2
|
Affiliation(s)
- Ladislav Habala
- Faculty of Pharmacy, Department of Chemical Theory of Drugs, Comenius University Bratislava, Slovakia
| | - Ferdinand Devínsky
- Faculty of Pharmacy, Department of Chemical Theory of Drugs, Comenius University Bratislava, Slovakia
| | | |
Collapse
|
|
3
|
Shi DH, Zhu HL, Liu YW, Tang ZM, Lu C, Ma XD, Song XK, Liu WW, Dong T, Song MQ. Synthesis and Evaluation of 5-Benzyl-1,3,4-Thiadiazole Derivatives as Acetylcholinesterase Inhibitors. JOURNAL OF CHEMICAL RESEARCH 2017. [DOI: 10.3184/174751917x15094552081242] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Three novel 5-benzyl-1,3,4-thiadiazole derivatives were synthesised starting from phenylacetic acid derivatives. These compounds were characterised by NMR, HRMS and single-crystal X-ray diffraction analysis. 2-Pyrrolidyl-5-[2-(4-bromophenyl)methyl]-1,3,4-thiadiazole showed moderate acetylcholinesterase-inhibition activity with a 50% inhibitory concentration value of 33.16 μM. 2-Pyrrolidyl-5-[2-(4-bromophenyl)methyl]-1,3,4-thiadiazole and acetylcholinesterase docking was demonstrated using the Molecular Operating Environment program.
Collapse
Affiliation(s)
- Da-Hua Shi
- Jiangsu Institute of Marine Resources, Huaihai Institute of Technology, Lianyungang 222005, P.R. China
- Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, Huaihai Institute of Technology, Lianyungang 222005, P.R. China
- Co-Innovation Center of Jiangsu Marine Bio-industry Technology, Lianyungang 222005, P.R. China
| | - Hui-Long Zhu
- Jiangsu Institute of Marine Resources, Huaihai Institute of Technology, Lianyungang 222005, P.R. China
- Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, Huaihai Institute of Technology, Lianyungang 222005, P.R. China
| | - Yu-Wei Liu
- Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, Huaihai Institute of Technology, Lianyungang 222005, P.R. China
| | - Zong-Ming Tang
- Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, Huaihai Institute of Technology, Lianyungang 222005, P.R. China
| | - Chen Lu
- Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, Huaihai Institute of Technology, Lianyungang 222005, P.R. China
| | - Xiao-Dong Ma
- Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, Huaihai Institute of Technology, Lianyungang 222005, P.R. China
| | - Xiao-Kai Song
- Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, Huaihai Institute of Technology, Lianyungang 222005, P.R. China
| | - Wei-Wei Liu
- Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, Huaihai Institute of Technology, Lianyungang 222005, P.R. China
| | - Tong Dong
- Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, Huaihai Institute of Technology, Lianyungang 222005, P.R. China
| | - Meng-Qiu Song
- Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, Huaihai Institute of Technology, Lianyungang 222005, P.R. China
| |
Collapse
|